---
layout: splash
title: 유한양행 (000100)
excerpt: 유한양행의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
keywords: 유한양행, 000100
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 90,800 | <span style="color: cornflowerblue">-1.3<small>%</small></span> | P:의약품 | 50.0 | 3.3 | 0.5<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 의약품(삐콤씨, 안티푸라민, 렉라자, 로수바미브, 코푸시럽 등), 생활용품(유한락스, 해피홈, 유한젠), 동물약품 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 1962년 11월 1일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 대표이사 조욱제 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.yuhan.co.kr](http://www.yuhan.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 08&#x2011;02 | | [임원ㆍ주요주주특정증권등소유상황보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240802000107){:target="_blank"} |
| 07&#x2011;30 | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000189){:target="_blank"} |
|  | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000183){:target="_blank"} |
|  | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000175){:target="_blank"} |
|  | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000167){:target="_blank"} |
|  | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000163){:target="_blank"} |
|  | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000156){:target="_blank"} |
|  | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000149){:target="_blank"} |
|  | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000144){:target="_blank"} |
|  | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000138){:target="_blank"} |
|  | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000135){:target="_blank"} |
|  | | [[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730000124){:target="_blank"} |
|  | | [영업(잠정)실적(공정공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240730800192){:target="_blank"} |
| 07&#x2011;29 | | [기업설명회(IR)개최(안내공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240729800203){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![000100](/stock/images/000100.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 90,800 | <span style="color: cornflowerblue">-1.3<small>%</small></span> | <span style="color: cornflowerblue">-5.1<small>%</small></span> | <span style="color: tomato">1.5<small>%</small></span> | <span style="color: tomato">25.2<small>%</small></span> | <span style="color: tomato">51.8<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">30.2<small>%</small></span> | 43.5<small>%</small> | 0.70 | -29.7<small>%</small> | -10.7<small>%</small> | -1.0 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 50.0 | 3.3 | 0.5<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/000100/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=000100){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A000100&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=000100){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/000100){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/000100/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![000100](/stock/images/000100_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 30.2<small>%</small> | 43.5<small>%</small> | 0.70 | -29.7<small>%</small> | -10.7<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 30.9<small>%</small> | 42.9<small>%</small> | 0.72 | -28.4<small>%</small> | -8.7<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 37.7<small>%</small> | 32.0<small>%</small> | 1.18 | -25.7<small>%</small> | -7.4<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 7.1<small>%</small> | 30.1<small>%</small> | 0.24 | -14.1<small>%</small> | -7.7<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 18.1<small>%</small> | 32.9<small>%</small> | 0.55 | -19.1<small>%</small> | -10.6<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 6.6<small>%</small> | 39.4<small>%</small> | 0.17 | -27.5<small>%</small> | -15.1<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 15.4<small>%</small> | 40.1<small>%</small> | 0.38 | -25.5<small>%</small> | -14.6<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 12.4<small>%</small> | 42.6<small>%</small> | 0.29 | -30.9<small>%</small> | -16.5<small>%</small> |
| MACD[^fn_tech_metric_macd] | 20.0<small>%</small> | 30.5<small>%</small> | 0.66 | -24.5<small>%</small> | -10.6<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![000100](/stock/images/000100_corr.png){: .align-center}

|       | [오스코텍](/039200/) | [두산](/000150/) | [두산에너빌리티](/034020/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [제룡전기](/033100/) | [대주전자재료](/078600/) | [에스티팜](/237690/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![000100](/stock/images/000100_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}